Clinical Trial Update: Diabetogenicity of Cyclosporine and Tacrolimus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether cyclosporine and tacrolimus increase the risk of new-onset diabetes after transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Posttransplant Diabetes Mellitus

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of Aarhus | Conditions: Complications of Transplanted Organs and Tissue, Diabetes Mellitus Nos New Onset | Phase 4 | Status: COMPLETED